ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
(State or other jurisdiction of incorporation or organization) |
(I.R.S. Employer Identification No.) | |
(Address of principal executive offices) (zip code) |
Title of Each Class |
Trading Symbols |
Name of Each Exchange on Which Registered | ||
one-fourth of one redeemable warrant |
||||
Large accelerated filer | ☐ | Accelerated filer | ☐ | |||
☒ | Smaller reporting company | |||||
Emerging growth company |
Page Number |
||||||
| ||||||
Item 1. |
1 |
|||||
Item 1A. |
3 |
|||||
Item 1B. |
33 |
|||||
Item 2. |
33 |
|||||
Item 3. |
33 |
|||||
Item 4. |
33 |
|||||
| ||||||
Item 5. |
34 |
|||||
Item 6. |
34 |
|||||
Item 7. |
35 |
|||||
Item 8. |
39 |
|||||
Item 9. |
59 |
|||||
Item 9A. |
59 |
|||||
Item 9B. |
59 |
|||||
Item 9C. |
59 |
|||||
| ||||||
Item 10. |
60 |
|||||
Item 11. |
66 |
|||||
Item 12. |
67 |
|||||
Item 13. |
68 |
|||||
Item 14. |
69 |
|||||
| ||||||
Item 15. |
70 |
|||||
Item 16. |
71 |
Item 1. |
Business |
Item 1A. |
Risk Factors |
• | our ability to complete our initial business combination; |
• | our success in retaining or recruiting, or changes required in, our officers, key employees or directors following our initial business combination; |
• | our officers and directors allocating their time to other businesses and potentially having conflicts of interest with our business or in approving our initial business combination; |
• | our potential ability to obtain additional financing to complete our initial business combination; |
• | our pool of prospective target businesses; |
• | the ability of our officers and directors to generate a number of potential investment opportunities; |
• | our public securities’ potential liquidity and trading; |
• | the use of proceeds not held in the trust account or available to us from interest income on the trust account balance; |
• | the trust account not being subject to claims of third parties; |
• | our financial performance following our IPO; or |
• | the other risks and uncertainties discussed in “Risk Factors” in this Annual Report. |
• | restrictions on the nature of our investments; and |
• | restrictions on the issuance of securities, each of which may make it difficult for us to complete our initial business combination. |
• | registration as an investment company; |
• | adoption of a specific form of corporate structure; and |
• | reporting, record keeping, voting, proxy and disclosure requirements and other rules and regulations. |
• | may significantly dilute the equity interest of investors in our Public Shares, which dilution would increase if the anti-dilution provisions in the Class B ordinary shares or Class C ordinary shares resulted in the issuance of Class A ordinary shares on a greater than one-to-one |
• | may subordinate the rights of holders of our Class A ordinary shares if preference shares are issued with rights senior to those afforded our Class A ordinary shares; |
• | could cause a change in control if a substantial number of Class A ordinary shares is issued, which may affect, among other things, our ability to use our net operating loss carry forwards, if any, and could result in the resignation or removal of our present officers and directors; |
• | may adversely affect prevailing market prices for our units, Class A ordinary shares and/or warrants; and |
• | will not result in adjustment to the exercise price of our warrants. |
• | solely dependent upon the performance of a single business, property or asset; or |
• | dependent upon the development or market acceptance of a single or limited number of products, processes or services. |
• | a limited availability of market quotations for our securities; |
• | reduced liquidity for our securities; |
• | a determination that our Class A ordinary shares are a “penny stock” which will require brokers trading in our Class A ordinary shares to adhere to more stringent rules and possibly result in a reduced level of trading activity in the secondary trading market for our securities; |
• | a limited amount of news and analyst coverage; and |
• | a decreased ability to issue additional securities or obtain additional financing in the future. |
• | default and foreclosure on our assets if our operating revenues after an initial business combination are insufficient to repay our debt obligations; |
• | acceleration of our obligations to repay the indebtedness even if we make all principal and interest payments when due if we breach certain covenants that require the maintenance of certain financial ratios or reserves without a waiver or renegotiation of that covenant; |
• | our immediate payment of all principal and accrued interest, if any, if the debt security is payable on demand; |
• | our inability to obtain necessary additional financing if the debt security contains covenants restricting our ability to obtain such financing while the debt security is outstanding; |
• | our inability to pay dividends on our Class A ordinary shares; |
• | using a substantial portion of our cash flow to pay principal and interest on our debt, which will reduce the funds available for dividends on our Class A ordinary shares if declared, our ability to pay expenses, make capital expenditures and acquisitions and fund other general corporate purposes; |
• | limitations on our flexibility in planning for and reacting to changes in our business and in the industry in which we operate; |
• | increased vulnerability to adverse changes in general economic, industry and competitive conditions and adverse changes in government regulation; and |
• | limitations on our ability to borrow additional amounts for expenses, capital expenditures, acquisitions, debt service requirements and execution of our strategy and other purposes and other disadvantages compared to our competitors who have less debt. |
• | we have a Board that includes a majority of ‘independent directors,’ as defined under the rules of the NYSE; |
• | we have a compensation committee of our Board that is comprised entirely of independent directors with a written charter addressing the committee’s purpose and responsibilities; and |
• | we have a nominating and corporate governance committee of our Board that is comprised entirely of independent directors with a written charter addressing the committee’s purpose and responsibilities. |
• | costs and difficulties inherent in managing cross-border business operations and complying with different commercial and legal requirements of overseas markets; |
• | rules and regulations regarding currency redemption; |
• | complex corporate withholding taxes on individuals; |
• | laws governing the manner in which future business combinations may be effected; |
• | exchange listing and/or delisting requirements; |
• | tariffs and trade barriers; |
• | regulations related to customs and import/export matters; |
• | local or regional economic policies and market conditions; |
• | unexpected changes in regulatory requirements; |
• | longer payment cycles; |
• | tax issues, such as tax law changes and variations in tax laws as compared to the United States; |
• | currency fluctuations and exchange controls; |
• | rates of inflation; |
• | challenges in collecting accounts receivable; |
• | cultural and language differences; |
• | employment regulations; |
• | underdeveloped or unpredictable legal or regulatory systems; |
• | corruption; |
• | protection of intellectual property; |
• | social unrest, crime, strikes, riots and civil disturbances; |
• | regime changes and political upheaval; |
• | terrorist attacks, natural disasters and wars; |
• | deterioration of political relations with the United States; and |
• | government appropriation of assets. |
Item 1B. |
Unresolved Staff Comments |
Item 2. |
Properties |
Item 3. |
Legal Proceedings |
Item 4. |
Mine Safety Disclosures |
Item 5. |
Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities |
Item 6. |
Reserved |
Item 7. |
Management’s Discussion and Analysis of Financial Condition and Results of Operations |
Item 8. |
Financial Statements and Supplementary Data |
Reports of Independent Registered Public Accounting Firm | 40 | |||
Consolidated Balance Sheets as of December 31, 2021 and December 31, 2020 | 41 | |||
Consolidated Statements of Operations for the year ended December 31, 2021 and for the period from December 21, 2020 (Inception) through December 31, 2020 | 42 | |||
Consolidated Statements of Changes in Shareholders’ Equity for the year ended December 31, 2021 and for the period from December 21, 2020 (Inception) through December 31, 2020 | 43 | |||
Consolidated Statements of Cash Flows for the year ended December 31, 2021 and for the period from December 21, 2020 (Inception) Through December 31, 2020 | 44 | |||
Notes to Consolidated Financial Statements | 45 | |||
(1) All supplemental schedules have been omitted since the information is either included in the financial statement or the notes thereto or they are not required or are not applicable. |
As of December 31, 2021 |
As of December 31, 2020 |
|||||||
ASSETS |
||||||||
Cash |
$ | $ | — | |||||
Prepaid expenses |
— | |||||||
Other current assets |
— | |||||||
|
|
|
|
|||||
Total current assets |
— | |||||||
Deferred offering costs |
— | |||||||
Cash held in Trust Account |
— | |||||||
Other assets |
— | |||||||
|
|
|
|
|||||
Total Assets |
$ |
$ |
||||||
|
|
|
|
|||||
LIABILITIES, ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION, AND SHAREHOLDERS’ DEFICIT |
||||||||
Current liabilities: |
||||||||
Accounts payable |
$ | $ | — | |||||
Due to related party |
||||||||
Accrued offering costs |
||||||||
Accrued expenses |
||||||||
|
|
|
|
|||||
Total current liabilities |
||||||||
Deferred underwriting fees payable |
— | |||||||
Derivative warrant liabilities |
— | |||||||
|
|
|
|
|||||
Total liabilities |
$ |
|||||||
Commitments and Contingencies (Note 6) |
||||||||
Class A ordinary shares subject to possible redemption, |
— | |||||||
Shareholders’ deficit |
||||||||
Preference shares, $ |
— | |||||||
Class A ordinary shares, $ |
— | |||||||
Class B ordinary shares, $ |
— | |||||||
Class C ordinary shares, $ - |
— | |||||||
Additional paid-in capital |
— | |||||||
Accumulated deficit |
( |
) | ( |
) | ||||
|
|
|
|
|||||
Total shareholders’ deficit |
( |
) |
( |
) | ||||
|
|
|
|
|||||
Total Liabilities, Ordinary Shares Subject to Possible Redemption, and Shareholders’ Deficit |
$ |
$ |
||||||
|
|
|
|
For The Year Ended December 31, 2021 |
For The Period From December 21, 2020 (Inception) Through December 31, 2020 |
|||||||
Formation and operating costs |
$ | $ | ||||||
|
|
|
|
|||||
Loss from operations |
( |
) | ( |
) | ||||
Change in fair value of derivative warrant liabilities |
— | |||||||
Offering costs allocated to derivative warrant liabilities |
( |
) | — | |||||
Other income |
— | |||||||
|
|
|
|
|||||
Net income (loss) |
$ | $ | ( |
) | ||||
|
|
|
|
|||||
Weighted average shares outstanding of Class A ordinary shares subject to possible redemption, basic and diluted |
— | |||||||
|
|
|
|
|||||
Basic and diluted net income (loss) per share, Class A ordinary shares subject to possible redemption |
$ |
$ |
||||||
|
|
|
|
|||||
Weighted average shares outstanding of Class B ordinary shares, basic and diluted |
||||||||
|
|
|
|
|||||
Basic and diluted net income (loss) per share, Class B ordinary shares |
$ |
$ |
( |
) | ||||
|
|
|
|
|||||
Weighted average shares outstanding of Class C ordinary shares, basic and diluted |
— | |||||||
|
|
|
|
|||||
Basic and diluted net income (loss) per share, Class C ordinary shares |
$ |
$ |
||||||
|
|
|
|
Ordinary Shares |
||||||||||||||||||||||||||||
Class B |
Class C |
|||||||||||||||||||||||||||
Shares |
Amount |
Shares |
Amount |
Additional Paid-In Capital |
Accumulated Deficit |
Total Shareholders’ Deficit |
||||||||||||||||||||||
Balance as of December 21, 2020 (inception) |
$ | $ | $ | $ | $ | |||||||||||||||||||||||
Issuance of Class B ordinary shares to Sponsor |
— | — | — | — | — | — | ||||||||||||||||||||||
Net loss |
— | — | — | — | — | ( |
) | ( |
) | |||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Balance as of December 31, 2020 |
$ |
$ |
$ |
$ |
( |
) |
$ |
( |
) | |||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ordinary Shares |
||||||||||||||||||||||||||||
Class B |
Class C |
|||||||||||||||||||||||||||
Shares |
Amount |
Shares |
Amount |
Additional Paid-In Capital |
Accumulated Deficit |
Total Shareholders’ Deficit |
||||||||||||||||||||||
Balance as of January 1, 2021 |
$ | $ | $ | $ | ( |
) | $ | ( |
) | |||||||||||||||||||
Issuance of Class B and Class C ordinary shares to Sponsor |
— | |||||||||||||||||||||||||||
Cancellation of Class B ordinary share to Sponsor |
( |
) | — | — | — | — | — | — | ||||||||||||||||||||
Adjustment of Class A ordinary shares to redemption value |
— | — | — | — | ( |
) | ( |
) | ( |
) | ||||||||||||||||||
Net income |
— | — | — | — | — | $ |
||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Balance as of December 31, 2021 |
$ |
$ |
$ |
$ |
( |
) |
$ |
( |
) | |||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For The Year Ended December 31, 2021 |
For The Period From December 21, 2020 (Inception) Through December 31, 2020 |
|||||||
Cash Flows from Operating Activities |
||||||||
Net income (loss) |
$ | $ | ( |
) | ||||
Adjustments to reconcile net income (loss) to net cash provided by operating activities: |
||||||||
Offering costs allocated to warrant liability |
— | |||||||
Formation and operating expenses funded by note payable through Sponsor |
||||||||
Gain on change in fair value of warrant liability |
( |
) | — | |||||
Changes in operating assets and liabilities: |
||||||||
Prepaid expenses |
( |
) | — | |||||
Other assets |
( |
) | — | |||||
Accounts payable |
— | |||||||
Accrued expenses |
— | |||||||
|
|
|
|
|||||
Net cash provided by operating activities |
||||||||
|
|
|
|
|||||
Cash Flows from Investing Activities |
||||||||
Investment of cash into Trust Account |
( |
) | — | |||||
|
|
|
|
|||||
Net cash used in investing activities |
( |
) | ||||||
|
|
|
|
|||||
Cash Flows from Financing Activities |
||||||||
Advances from related party |
— | |||||||
Repayment of promissory note - related party |
( |
) | — | |||||
Proceeds from sale of Units, net of offering costs |
— | |||||||
Proceeds from sale of Private Placement Warrants |
— | |||||||
|
|
|
|
|||||
Net cash provided by financing activities |
||||||||
|
|
|
|
|||||
Net increase in cash |
||||||||
Cash - beginning of period |
||||||||
|
|
|
|
|||||
Cash - end of period |
$ | $ | ||||||
|
|
|
|
|||||
Supplemental disclosure of noncash investing and financing activities: |
||||||||
Issuance of Class B and Class C ordinary shares to Sponsor as settlement of due to related party |
$ | $ | — | |||||
|
|
|
|
|||||
Deferred offering costs included in accrued expenses |
$ | $ | — | |||||
|
|
|
|
|||||
Deferred offering costs paid through promissory note - related party |
$ | $ | ||||||
|
|
|
|
|||||
Deferred underwriting fees payable |
$ | $ | ||||||
|
|
|
|
Gross proceeds from sale of Class A ordinary shares |
$ | |||
Less: Allocation to public warrants |
( |
) | ||
Less: Issuance costs attributable to Class A ordinary shares |
( |
) | ||
Adjustment of Class A ordinary shares to redemption value |
||||
|
|
|||
Class A ordinary shares subject to possible redemption |
$ |
|||
|
|
• | Level 1, defined as observable inputs such as quoted prices for identical instruments in active markets; |
• | Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and |
• | Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. |
For The Year Ended December 31, 2021 |
||||
Redeemable Class A Ordinary Shares |
||||
Net earnings allocable to Redeemable Class A Ordinary Shares |
$ | |||
Basic and diluted weighted average shares outstanding, Redeemable Class A ordinary shares |
||||
|
|
|||
Basic and diluted net earnings per share, Redeemable Class A ordinary shares |
$ | |||
|
|
|||
Non-Redeemable Class B and Class C Ordinary Shares |
||||
Net earnings allocable to non-redeemable Class B Ordinary Shares |
$ | |||
Basic and diluted weighted average shares outstanding, Non-Redeemable Class B ordinary shares |
||||
|
|
|||
Basic and diluted weighted average shares outstanding, Non-Redeemable Class B |
$ | |||
|
|
|||
Non-Redeemable Class C Ordinary Shares |
||||
Net earnings allocable to non-redeemable Class C Ordinary Shares |
$ | |||
Basic and diluted weighted average shares outstanding, Non-Redeemable Class C ordinary shares |
||||
|
|
|||
Basic and diluted weighted average shares outstanding, Non-Redeemable Class C |
$ | |||
|
|
March 2, 2021 |
||||||||||||
As reported |
Adjustment |
Restated |
||||||||||
Warrant liability |
$ | $ |
$ | |||||||||
Total liabilities |
||||||||||||
Class A ordinary shares subject to possible redemption (temporary equity) |
||||||||||||
Shareholders’ Equity: |
||||||||||||
Class A ordinary shares |
( |
) | ||||||||||
Additional paid-in capital |
( |
) | ||||||||||
Accumulated deficit |
( |
) | ( |
) | ( |
) | ||||||
|
|
|
|
|
|
|||||||
Total Shareholders’ Equity |
$ | $ |
( |
) | $ | ( |
) | |||||
|
|
|
|
|
|
• | in whole and not in part; |
• | at a price of $ |
• | upon a minimum of 30 days’ prior written notice of redemption to each warrant holder; and |
• | if, and only if, the last reported sale price of the Class A ordinary shares for any sub-divisions, share capitalizations, reorganizations, recapitalizations and the like). |
• | in whole and not in part; |
• | at $ |
• | if, and only if, the Reference Value equals or exceeds $ sub-divisions, share dividends, reorganizations, recapitalizations and the like); and |
• | if the Reference Value is less than $ sub-divisions, share dividends, reorganization, recapitalizations and the like) the private placement warrants must also be concurrently called for redemption on the same terms as the outstanding Public Warrants, as described above. |
Level 1 |
Level 2 |
Level 3 |
Total |
|||||||||||||
Liabilities: |
||||||||||||||||
Public Warrants |
$ | |
$ | — | $ | — | $ | |
||||||||
Private Placement Warrants |
— | |||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total liabilities |
$ | $ | |
$ | $ | |||||||||||
|
|
|
|
|
|
|
|
Public Warrant Liability |
Private Placement Warrant Liability |
Total |
||||||||||
Fair value, March 2, 2021 |
$ | ( |
) | $ | ( |
) | $ | ( |
) | |||
Change in fair value |
( |
) | ( |
) | ( |
) | ||||||
Transfer to level 1 |
||||||||||||
Transfer to level 2 |
||||||||||||
Fair value, December 31, 2021 |
$ | $ | $ | |||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
Item 9. |
Changes in and Disagreements with Accountants on Accounting and Financial Disclosure |
Item 9A. |
Controls and Procedures |
Item 9B. |
Other Information |
Item 9C. |
Disclosure Regarding Foreign Jurisdictions that Prevent Inspections. |
Item 10. |
Directors, Executive Officers and Corporate Governance |
Name |
Age |
Position | ||
William P. Foley, II | 77 | Founder | ||
Hugh R. Harris | 70 | Director | ||
Mark D. Linehan | 59 | Director | ||
Erika Meinhardt | 63 | Director | ||
Dexter Fowler | 35 | Director | ||
Richard N. Massey | 66 | Chief Executive Officer and Director | ||
David W. Ducommun | 45 | President | ||
Bryan D. Coy | 52 | Chief Financial Officer | ||
Ryan R. Caswell | 39 | Senior Vice President of Corporate Finance | ||
Michael L. Gravelle |
60 | General Counsel and Corporate Secretary |
• | appointing, compensating and overseeing our independent registered public accounting firm; |
• | reviewing and approving the annual audit plan for the Company; |
• | overseeing the integrity of our financial statements and our compliance with legal and regulatory requirements; |
• | discussing the annual audited financial statements and unaudited quarterly financial statements with management and the independent registered public accounting firm; |
• | pre-approving all audit services and permitted non-audit services to be performed by our independent registered public accounting firm, including the fees and terms of the services to be performed; |
• | appointing or replacing the independent registered public accounting firm; |
• | establishing procedures for the receipt, retention and treatment of complaints (including anonymous complaints) we receive concerning accounting, internal accounting controls, auditing matters or potential violations of law; |
• | monitoring our environmental sustainability and governance practices; |
• | establishing procedures for the receipt, retention and treatment of complaints received by us regarding accounting, internal accounting controls or reports which raise material issues regarding our financial statements or accounting policies; |
• | discussing earnings press releases and financial information provided to analysts and rating agencies; |
• | discussing with management our policies and practices with respect to risk assessment and risk management; |
• | reviewing any material transaction between our Chief Financial Officer that has been approved in accordance with our Code of Ethics for our officers, and providing prior written approval of any material transaction between us and our President; and |
• | producing an annual report for inclusion in our proxy statement, in accordance with applicable rules and regulations. |
• | reviewing and approving corporate goals and objectives relevant to our President’s compensation, evaluating our President’s performance in light of those goals and objectives, and setting our President’s compensation level based on this evaluation; |
• | setting salaries and approving incentive compensation and equity awards, as well as compensation policies, for all other officers who file reports of their ownership, and changes in ownership, of the Company’s common stock under Section 16(a) of the Exchange Act (the “Section 16 Officers”), as designated by our board of directors; |
• | making recommendations to the board with respect to incentive compensation programs and equity-based plans that are subject to board approval; |
• | approving any employment or severance agreements with our Section 16 Officers; |
• | granting any awards under equity compensation plans and annual bonus plans to our President and the Section 16 Officers; |
• | approving the compensation of our directors; and |
• | producing an annual report on executive compensation for inclusion in our proxy statement, in accordance with applicable rules and regulations. |
• | identifying individuals qualified to become members of the board of directors and making recommendations to the board of directors regarding nominees for election; |
• | reviewing the independence of each director and making a recommendation to the board of directors with respect to each director’s independence; |
• | developing and recommending to the board of directors the corporate governance principles applicable to us and reviewing our corporate governance guidelines at least annually; |
• | making recommendations to the board of directors with respect to the membership of the audit, compensation and corporate governance and nominating committees |
• | overseeing the evaluation of the performance of the board of directors and its committees on a continuing basis, including an annual self-evaluation of the performance of the corporate governance and nominating committee; |
• | considering the adequacy of our governance structures and policies, including as they relate to our environmental sustainability and governance practices; |
• | considering director nominees recommended by stockholders; and |
• | reviewing our overall corporate governance and reporting to the board of directors on its findings and any recommendations. |
• | should possess personal qualities and characteristics, accomplishments and reputation in the business community; |
• | should have current knowledge and contacts in the communities in which we do business and in our industry or other industries relevant to our business; |
• | should have the ability and willingness to commit adequate time to the board of directors and committee matters; |
• | should demonstrate ability and willingness to commit adequate time to the board of directors and committee matters; |
• | should possess the fit of the individual’s skills and personality with those of other directors and potential directors in building a board of directors that is effective, collegial and responsive to our needs; and |
• | should demonstrate diversity of viewpoints, background, experience, and other demographics, and all aspects of diversity in order to enable the board to perform its duties and responsibilities effectively, including candidates with a diversity of age, gender, nationality, race, ethnicity, and sexual orientation. |
• | duty to act in good faith in what the director or officer believes to be in the best interests of the company as a whole; |
• | duty to exercise powers for the purposes for which those powers were conferred and not for a collateral purpose; |
• | directors should not improperly fetter the exercise of future discretion; |
• | duty to exercise powers fairly as between different sections of shareholders; |
• | duty not to put themselves in a position in which there is a conflict between their duty to the company and their personal interests; and |
• | duty to exercise independent judgment. |
Item 11. |
Executive Compensation |
Item 12. |
Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters |
• | each person known by us to be a beneficial owner of more than 5% of our outstanding ordinary shares, on an as-converted basis; |
• | each of our officers and directors; and |
• | all of our officers and directors as a group. |
Name and Address of Beneficial Owner (1) |
Number of Shares Beneficially Owned |
Percentage of Outstanding Ordinary Shares |
||||||
Austerlitz Acquisition Sponsor, LP II (2)(3) |
29,371,430 | 29.9 | % | |||||
William P. Foley, II (2)(3) |
29,371,430 | 29.9 | % | |||||
Dexter Fowler (4) |
50,000 | * | ||||||
Hugh R. Harris (4) |
50,000 | * | ||||||
Mark D. Linehan (4) |
50,000 | * | ||||||
Erika Meinhardt (4) |
50,000 | * | ||||||
Richard N. Massey |
— | — | ||||||
David W. Ducommun |
— | — | ||||||
Bryan D. Coy |
900 | * | ||||||
Ryan R. Caswell |
— | — | ||||||
Michael L. Gravelle |
25,000 | * | ||||||
All officers and directors as a group (9 individuals) |
225,900 | * |
* | Less than one percent |
(1) | Unless otherwise noted, the business address of each of our shareholders is 1701 Village Center Circle, Las Vegas, NV, 89134. |
(2) | Interests shown consist of 14,785,715 Class B ordinary shares, and 14,785,715 Class C ordinary shares. Such shares will convert into Class A ordinary shares on a one-for-one |
(3) | The securities are held directly by Austerlitz Acquisition Sponsor LP, I (the “Austerlitz Sponsor I”) and indirectly by (i) Trasimene Capital AU, LP I, the sole general partner of the Austerlitz Sponsor (the “Austerlitz GP I”), (ii) Trasimene Capital AU, Corp. I, the sole general partner of Austerlitz GP I (“Trasimene AU Corp. I”), and (iii) William P. Foley, II, the sole shareholder of Trasimene AU Corp. I. As a result, Austerlitz Sponsor I, the Austerlitz GP I, Trasimene AU Corp. I and Mr. Foley may be deemed to have or share beneficial ownership of the securities held directly by the Austerlitz Sponsor I. Each of the Austerlitz GP, Trasimene AU Corp. and Mr. Foley disclaims beneficial ownership of such securities except to the extent of their respective pecuniary interest therein, if any. |
(4) | Interests shown consist of 25,000 Class B ordinary shares and 25,000 Class C ordinary shares. Such shares will convert into Class A ordinary shares on a one-for-one |
Item 13. |
Certain Relationships and Related Transactions |
Item 14. |
Principal Accounting Fees and Services |
For the year ended December 31, 2021 |
||||
Audit Fees (1) |
$ | 140,595 | ||
All Other Fees (2) |
38,110 | |||
|
|
|||
Total Fees |
$ | 178,705 | ||
|
|
(1) | Audit Fees consist of fees billed for professional services rendered for the audit of our Initial Public Offering, audit of our year-end financial statements and quarterly review services. |
(2) | All Other Fees consist of fees billed for professional services rendered for our registration statement on Form S-4 in conjunction with our terminated business combination with WIL. |
Item 15. |
Exhibits, Financial Statement Schedules and Reports on Form 8-K |
* | Filed herewith |
** | Furnished herewith |
(1) | Previously filed as an exhibit to our Current Report on Form 8-K filed on March 3, 2021 and incorporated by reference herein. |
(2) | Previously filed as an exhibit to our IPO Prospectus and incorporated by reference herein. |
(3) | The instance document does not appear in the interactive data file because its XBRL tags are embedded within the inline XBRL document. |
Item 16. |
Form 10-K Summary |
Austerlitz Acquisition Corporation I | ||
By: | /s/ David W. Ducommun | |
David W. Ducommun | ||
President (Principal Executive Officer) |
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the Registrant and in the capacities and on the dates indicated. | ||||
Signature |
Title |
Date | ||
/s/ David W. Ducommun |
President | March 16, 2022 | ||
David W. Ducommun | (Principal Executive Officer) | |||
/s/ Bryan D. Coy |
Chief Financial Officer | March 16, 2022 | ||
Bryan D. Coy | (Principal Financial and Accounting Officer) | |||
/s/ Dexter Fowler |
Director | March 16, 2022 | ||
Dexter Fowler | ||||
/s/ Hugh R. Harris |
Director | March 16, 2022 | ||
Hugh R. Harris | ||||
/s/ Mark D. Linehan |
Director | March 16, 2022 | ||
Mark D. Linehan | ||||
/s/ Richard N. Massey |
Director | March 16, 2022 | ||
Richard N. Massey | ||||
/s/ Erika Meinhardt |
Director | March 16, 2022 | ||
Erika Meinhardt |